89bio Inc (ETNB)
8.38
+0.40
(+5.01%)
USD |
NASDAQ |
Nov 21, 16:00
8.38
0.00 (0.00%)
After-Hours: 20:00
89bio Total Liabilities (Quarterly): 80.20M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 80.20M |
| June 30, 2024 | 67.22M |
| March 31, 2024 | 66.78M |
| December 31, 2023 | 59.96M |
| September 30, 2023 | 49.90M |
| June 30, 2023 | 50.52M |
| March 31, 2023 | 48.49M |
| December 31, 2022 | 44.99M |
| September 30, 2022 | 48.00M |
| June 30, 2022 | 67.41M |
| March 31, 2022 | 33.02M |
| December 31, 2021 | 36.46M |
| Date | Value |
|---|---|
| September 30, 2021 | 21.29M |
| June 30, 2021 | 9.006M |
| March 31, 2021 | 8.459M |
| December 31, 2020 | 8.113M |
| September 30, 2020 | 9.424M |
| June 30, 2020 | 6.791M |
| March 31, 2020 | 7.787M |
| December 31, 2019 | 5.609M |
| September 30, 2019 | 72.32M |
| June 30, 2019 | 9.537M |
| December 31, 2018 | 27.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.609M
Minimum
Dec 2019
80.20M
Maximum
Sep 2024
36.47M
Average
40.73M
Median
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 296.11M |
| Eli Lilly and Co | 61.29B |
| Viking Therapeutics Inc | 26.44M |
| Akero Therapeutics Inc | 79.22M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 458.30M |
| Shareholders Equity (Quarterly) | 378.10M |